RAFAEL HOLDINGS, INC. Increase (Decrease) in Due to Related Parties, Current
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Due to Related Parties, Current of -$8.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2026-04-30 was -$18.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2026-01-31 was -$18.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2025-10-31 was $28.00K, a 2700.00% increase year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2025-07-31 was $59.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2025 was -$10.00K, a 107.25% decline from fiscal 2024.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2024 was $138.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2023 was -$43.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2022 was -$67.00K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2026-04-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$36.00K derived: sum of 2 quarters · filed 2026-06-11 | -$8.00K 10-Q · filed 2026-06-11 | $51.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | $10.00K 10-Q · filed 2026-03-16 | $69.00K derived: sum of 3 quarters · filed 2026-03-16 | $2.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | $28.00K 10-Q · filed 2025-12-12 | $87.00K derived: sum of 2 quarters · filed 2025-12-12 | $20.00K derived: sum of 3 quarters · filed 2026-06-11 | $17.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-07-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$8.00K derived: sum of 2 quarters · filed 2026-06-11 | -$11.00K derived: sum of 3 quarters · filed 2026-06-11 | -$10.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$70.00K derived: sum of 2 quarters · filed 2026-06-11 | -$69.00K 10-Q · filed 2026-06-11 | -$79.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$2.00K 10-Q · filed 2026-03-16 | -$12.00K derived: sum of 3 quarters · filed 2026-03-16 | $93.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | $1.00K 10-Q · filed 2025-12-12 | -$9.00K derived: sum of 2 quarters · filed 2025-12-12 | $96.00K derived: sum of 3 quarters · filed 2025-12-12 | $142.00K derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $95.00K derived: sum of 2 quarters · filed 2025-10-29 | $141.00K derived: sum of 3 quarters · filed 2025-10-29 | $138.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | $105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | $151.00K derived: sum of 2 quarters · filed 2025-06-11 | $148.00K 10-Q · filed 2025-06-11 | $145.00K derived: sum of 4 quarters · filed 2025-06-11 |
| 2024-01-31 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $43.00K 10-Q · filed 2025-03-14 | $40.00K derived: sum of 3 quarters · filed 2025-03-14 | $69.00K derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-10-31 | -$3.00K 10-Q · filed 2024-12-11 | -$6.00K derived: sum of 2 quarters · filed 2024-12-20 | $23.00K derived: sum of 3 quarters · filed 2024-12-20 | |
| 2023-07-31 | -$3.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $26.00K derived: sum of 2 quarters · filed 2024-12-20 | -$43.00K 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$40.00K 10-Q · filed 2024-06-14 | ||
| 2023-01-31 | -$69.00K 10-Q · filed 2024-03-14 | |||
| 2022-07-31 | -$67.00K 10-K · filed 2023-10-30 | |||
| 2020-10-31 | $30.00K 10-Q · filed 2020-12-15 | |||
| 2020-07-31 | -$65.00K 10-K · filed 2020-10-29 | |||
| 2019-10-31 | -$37.00K 10-Q · filed 2020-12-15 | |||
| 2019-07-31 | $654.00K 10-K · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |